Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 248

1.

Somatostatin Imaging of Neuroendocrine-Differentiated Prostate Cancer.

Hope TA, Aggarwal R, Simko JP, VanBrocklin HF, Ryan CJ.

Clin Nucl Med. 2015 Mar 17. [Epub ahead of print]

PMID:
25783510
2.

Genome-wide epistatic expression quantitative trait loci discovery in four human tissues reveals the importance of local chromosomal interactions governing gene expression.

Fitzpatrick DJ, Ryan CJ, Shah N, Greene D, Molony C, Shields DC.

BMC Genomics. 2015 Feb 21;16(1):109. [Epub ahead of print]

PMID:
25765234
Free PMC Article
3.

Kidney cancer, version 3.2015.

Motzer RJ, Jonasch E, Agarwal N, Beard C, Bhayani S, Bolger GB, Chang SS, Choueiri TK, Costello BA, Derweesh IH, Gupta S, Hancock SL, Kim JJ, Kuzel TM, Lam ET, Lau C, Levine EG, Lin DW, Michaelson MD, Olencki T, Pili R, Plimack ER, Rampersaud EN, Redman BG, Ryan CJ, Sheinfeld J, Shuch B, Sircar K, Somer B, Wilder RB, Dwyer M, Kumar R.

J Natl Compr Canc Netw. 2015 Feb;13(2):151-9.

PMID:
25691606
4.

Radiographic Progression-Free Survival As a Response Biomarker in Metastatic Castration-Resistant Prostate Cancer: COU-AA-302 Results.

Morris MJ, Molina A, Small EJ, de Bono JS, Logothetis CJ, Fizazi K, de Souza P, Kantoff PW, Higano CS, Li J, Kheoh T, Larson SM, Matheny SL, Naini V, Burzykowski T, Griffin TW, Scher HI, Ryan CJ.

J Clin Oncol. 2015 Jan 26. pii: JCO.2014.55.3875. [Epub ahead of print]

PMID:
25624432
5.

Clinical cancer advances 2015: annual report on progress against cancer from the american society of clinical oncology.

Masters GA, Krilov L, Bailey HH, Brose MS, Burstein H, Diller LR, Dizon DS, Fine HA, Kalemkerian GP, Moasser M, Neuss MN, O'Day SJ, Odenike O, Ryan CJ, Schilsky RL, Schwartz GK, Venook AP, Wong SL, Patel JD.

J Clin Oncol. 2015 Mar 1;33(7):786-809. doi: 10.1200/JCO.2014.59.9746. Epub 2015 Jan 20. No abstract available.

PMID:
25605863
6.

Transitions of care in heart failure: a scientific statement from the american heart association.

Albert NM, Barnason S, Deswal A, Hernandez A, Kociol R, Lee E, Paul S, Ryan CJ, White-Williams C; American Heart Association Complex Cardiovascular Patient and Family Care Committee of the Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Quality of Care and Outcomes Research.

Circ Heart Fail. 2015 Mar;8(2):384-409. doi: 10.1161/HHF.0000000000000006. Epub 2015 Jan 20.

PMID:
25604605
7.

Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study.

Ryan CJ, Smith MR, Fizazi K, Saad F, Mulders PF, Sternberg CN, Miller K, Logothetis CJ, Shore ND, Small EJ, Carles J, Flaig TW, Taplin ME, Higano CS, de Souza P, de Bono JS, Griffin TW, De Porre P, Yu MK, Park YC, Li J, Kheoh T, Naini V, Molina A, Rathkopf DE; COU-AA-302 Investigators.

Lancet Oncol. 2015 Feb;16(2):152-60. doi: 10.1016/S1470-2045(14)71205-7. Epub 2015 Jan 16.

PMID:
25601341
8.

Improvements in Radiographic Progression-Free Survival Stratified by ERG Gene Status in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Abiraterone Acetate.

Attard G, de Bono JS, Logothetis CJ, Fizazi K, Mukherjee SD, Joshua AM, Schrijvers D, van den Eertwegh AJ, Li W, Molina A, Griffin TW, Kheoh T, Ricci DS, Zelinsky K, Rathkopf DE, Scher HI, Ryan CJ.

Clin Cancer Res. 2015 Jan 15. [Epub ahead of print]

PMID:
25593303
9.

Meta-analysis of suicide rates among psychiatric in-patients.

Walsh G, Sara G, Ryan CJ, Large M.

Acta Psychiatr Scand. 2015 Mar;131(3):174-84. doi: 10.1111/acps.12383. Epub 2015 Jan 5.

PMID:
25559375
10.

Intermittent Chemotherapy as a Platform for Testing Novel Agents in Patients With Metastatic Castration-Resistant Prostate Cancer: A Department of Defense Prostate Cancer Clinical Trials Consortium Randomized Phase II Trial of Intermittent Docetaxel With Prednisone With or Without Maintenance GM-CSF.

Aggarwal RR, Beer TM, Weinberg VK, Higano C, Taplin ME, Ryan CJ, Lin AM, Alumkal J, Graff JN, Nordquist LT, Herrera I, Small EJ.

Clin Genitourin Cancer. 2014 Dec 9. pii: S1558-7673(14)00264-X. doi: 10.1016/j.clgc.2014.12.004. [Epub ahead of print]

PMID:
25557266
11.

Hair, hormones, and high-risk prostate cancer.

Ryan CJ, Chan JM.

J Clin Oncol. 2015 Feb 10;33(5):386-7. doi: 10.1200/JCO.2014.58.5588. Epub 2014 Dec 29. No abstract available.

PMID:
25547509
12.

Preventing suicide in the emergency department.

Ryan CJ, Large MM.

J Emerg Med. 2015 Mar;48(3):335-6. doi: 10.1016/j.jemermed.2013.08.154. Epub 2014 Dec 10. No abstract available.

PMID:
25497844
13.

Meta-analysis of the association between suicidal ideation and later suicide among patients with either a schizophrenia spectrum psychosis or a mood disorder.

Chapman CL, Mullin K, Ryan CJ, Kuffel A, Nielssen O, Large MM.

Acta Psychiatr Scand. 2015 Mar;131(3):162-73. doi: 10.1111/acps.12359. Epub 2014 Oct 31.

PMID:
25358861
14.

Sequential use of the androgen synthesis inhibitors ketoconazole and abiraterone acetate in castration-resistant prostate cancer and the predictive value of circulating androgens.

Kim W, Zhang L, Wilton JH, Fetterly G, Mohler JL, Weinberg V, Morse A, Szmulewitz RZ, Friedlander TW, Fong L, Lin AM, Harzstark AL, Molina A, Small EJ, Ryan CJ.

Clin Cancer Res. 2014 Dec 15;20(24):6269-76. doi: 10.1158/1078-0432.CCR-14-1595. Epub 2014 Oct 21.

PMID:
25336698
15.

Evolutionarily conserved genetic interactions with budding and fission yeast MutS identify orthologous relationships in mismatch repair-deficient cancer cells.

Tosti E, Katakowski JA, Schaetzlein S, Kim HS, Ryan CJ, Shales M, Roguev A, Krogan NJ, Palliser D, Keogh MC, Edelmann W.

Genome Med. 2014 Sep 17;6(9):68. doi: 10.1186/s13073-014-0068-4. eCollection 2014.

16.

Suicide explained!

Ryan CJ.

Aust N Z J Psychiatry. 2015 Jan;49(1):83-4. doi: 10.1177/0004867414551997. Epub 2014 Sep 19. No abstract available.

PMID:
25239475
17.

Quo vadis: advanced prostate cancer-clinical care and clinical research in the era of multiple androgen receptor-directed therapies.

Kim W, Ryan CJ.

Cancer. 2015 Feb 1;121(3):361-71. doi: 10.1002/cncr.28929. Epub 2014 Sep 18.

PMID:
25236176
18.

Bone-targeting radiopharmaceuticals for the treatment of bone-metastatic castration-resistant prostate cancer: exploring the implications of new data.

Ryan CJ, Saylor PJ, Everly JJ, Sartor O.

Oncologist. 2014 Oct;19(10):1012-8. doi: 10.1634/theoncologist.2013-0472. Epub 2014 Sep 17.

PMID:
25232039
19.

'Heed not the oracle': risk assessment has no role in preventing suicide in schizophrenia.

Large MM, Ryan CJ.

Acta Psychiatr Scand. 2014 Dec;130(6):415-7. doi: 10.1111/acps.12333. Epub 2014 Sep 18. No abstract available.

PMID:
25230911
20.

Population pharmacokinetic analysis of abiraterone in chemotherapy-naïve and docetaxel-treated patients with metastatic castration-resistant prostate cancer.

Stuyckens K, Saad F, Xu XS, Ryan CJ, Smith MR, Griffin TW, Yu MK, Vermeulen A, Nandy P, Poggesi I.

Clin Pharmacokinet. 2014 Dec;53(12):1149-60. doi: 10.1007/s40262-014-0178-6.

PMID:
25204404
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk